Multiple Manufacturers

AGGRASTAT

Manufacturer:

Multiple Manufacturers

Aggrastat HCPCS:

J3246

HCPCS Code Descriptor:

Injection, tirofiban hcl, 0.25 mg

Category:

J Code

Aggrastat NDCs:

25208-0002-02, 55150-0430-01, 25208-0002-01, 25208-0002-03, 55150-0429-01, 25208-0001-04

Primary Type:

Anti-platelet

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

25208-0002-01, 25208-0002-03, 25208-0001-04

About Aggrastat:

AGGRASTAT is an Anti-platelet drug manufactured by Medicure Pharma and administered via the Intravenous route of administration. The J Code: J3246 is aligned to the drug AGGRASTAT.

ACCESS PRICING AND MORE BY REGISTERING

J3246 Added Date:

January 1, 2005

J3246 Effective Date:

January 1, 2023

J3246 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Aggrastat billing and coding information.
Our team did not identify a source for Aggrastat patient assistance information. Please reach out to our team if you feel that this is a mistake.
AGGRASTAT prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for AGGRASTAT. Please check back in a few weeks.